Lamotrigina Kern Pharma

Lamotrigine, the active ingredient in Lamotrigina Kern Pharma, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of epilepsy, including partial and generalized tonic‑clonic seizures, and for maintenance therapy in bipolar disorder to help stabilize mood.

GNH USA supplies Lamotrigina Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used to manage seizure disorders and mood stabilization in bipolar disorder.

Epilepsy (partial seizures, generalized tonic‑clonic seizures): reduces seizure frequency and severity. Bipolar disorder (maintenance therapy): helps maintain mood stability and prevents recurrence of depressive or manic episodes.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash - Blurred vision - Fatigue

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions such as drug reaction with eosinophilia and systemic symptoms (DRESS) - Blood dyscrasias including agranulocytosis or aplastic anemia - Hepatic failure or severe liver injury - Suicidal thoughts or behavior - Severe hypersensitivity reactions

Before prescribing lamotrigine, clinicians should consider several precautionary measures.

Pregnancy: Category B – use only if the potential benefit justifies the potential risk to the fetus. Renal impairment: Adjust dosage as needed and monitor renal function. Hepatic impairment: Use with caution; monitor liver enzymes regularly. Concomitant valproic acid: Increases risk of serious skin reactions; consider alternative therapy. Abrupt discontinuation: May precipitate seizures; taper the dose under medical supervision. Store at room temperature: Keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines, requiring careful management.

Major Interactions (Avoid): - Valproic acid: Increases risk of severe skin reactions and raises lamotrigine plasma levels. - Carbamazepine: Lowers lamotrigine concentrations, potentially reducing efficacy. - Oral contraceptives: Accelerate lamotrigine clearance, possibly decreasing therapeutic effect.

Moderate Interactions (Monitor Closely): - Serotonergic agents (e.g., SSRIs, SNRIs): Monitor for signs of serotonin syndrome. - Alcohol: May enhance central nervous system depression and affect seizure threshold.